Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients
NCT ID: NCT04694729
Last Updated: 2021-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
54 participants
INTERVENTIONAL
2021-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Telerehabilitation in Patients With COPD
NCT04879576
The Effectiveness Pulmonary Telerehabilitation and Cognitive Telerehabilitation in COPD Patients
NCT05222295
Telerehabilitation in COPD
NCT05053061
The Effect of Telerehabilitation-Based Respiratory Exercise Programs on Lung Capacity
NCT06303479
Telerehabilitation in Patients With Fibrosing Interstitial Lung Diseases
NCT05166057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Videoconference-based
videoconference-based
Exercises will be done 3 days a week for 6 weeks, with the help of a physiotherapist via video conference.
control group
Video-based
video-based
The exercise video will be sent to the patients and they will do it 3 days a week for 6 weeks. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling once a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
videoconference-based
Exercises will be done 3 days a week for 6 weeks, with the help of a physiotherapist via video conference.
video-based
The exercise video will be sent to the patients and they will do it 3 days a week for 6 weeks. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling once a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years old
* Have the ability to use a smartphone
Exclusion Criteria
* Dizziness, significant sensory or motor impairments, dementia or terminal illnesses that prevent education
* Serious comorbidities such as unstable heart disease, irregular diabetes, known malignant disease, any other disease that makes the patient unsuitable for participation in the study.
* Incompatible patient
* Severe vision or hearing impairment
* Unwillingness or inability to follow the protocol
* Have had a COPD exacerbation in the previous 6 weeks
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nursima Bulut
Physiotherapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TeleCOPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.